These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32372343)

  • 1. Quantitative Assessment of Hippocampal Tau Pathology in AD and PART.
    Zhang L; Jiang Y; Zhu J; Liang H; He X; Qian J; Lin H; Tao Y; Zhu K
    J Mol Neurosci; 2020 Nov; 70(11):1808-1811. PubMed ID: 32372343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.
    Milenkovic I; Petrov T; Kovacs GG
    Dement Geriatr Cogn Disord; 2014; 38(5-6):375-88. PubMed ID: 25195847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomeric, phosphorylated, and truncated tau and spliceosome pathology within the entorhinal-hippocampal connectome across stages of Alzheimer's disease.
    Mahady LJ; Perez SE; Malek-Ahmadi M; Mufson EJ
    J Comp Neurol; 2023 Dec; 531(18):2080-2108. PubMed ID: 36989381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Vulnerability of Hippocampal Subfields in Primary Age-Related Tauopathy and Chronic Traumatic Encephalopathy.
    Farrell K; Iida MA; Cherry JD; Casella A; Stein TD; Bieniek KF; Walker JM; Richardson TE; White CL; Alvarez VE; Huber BR; Dickson DW; Insausti R; Dams-O'Connor K; ; McKee AC; Crary JF
    J Neuropathol Exp Neurol; 2022 Sep; 81(10):781-789. PubMed ID: 36004533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential vulnerability of the dentate gyrus to tauopathies in dementias.
    Kawles A; Minogue G; Zouridakis A; Keszycki R; Gill N; Nassif C; Coventry C; Zhang H; Rogalski E; Flanagan ME; Castellani R; Bigio EH; Mesulam MM; Geula C; Gefen T
    Acta Neuropathol Commun; 2023 Jan; 11(1):1. PubMed ID: 36597124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between hippocampal amyloid beta burden and spatial distribution of neurofibrillary degeneration.
    Walker JM; Goette W; Farrell K; Iida MA; Karlovich E; ; White CL; Crary JF; Richardson TE
    Alzheimers Dement; 2023 Jul; 19(7):3158-3170. PubMed ID: 36738450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.
    Cherry JD; Esnault CD; Baucom ZH; Tripodis Y; Huber BR; Alvarez VE; Stein TD; Dickson DW; McKee AC
    Acta Neuropathol Commun; 2021 May; 9(1):86. PubMed ID: 33980303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau pathology in Creutzfeldt-Jakob disease revisited.
    Kovacs GG; Rahimi J; Ströbel T; Lutz MI; Regelsberger G; Streichenberger N; Perret-Liaudet A; Höftberger R; Liberski PP; Budka H; Sikorska B
    Brain Pathol; 2017 May; 27(3):332-344. PubMed ID: 27377321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways.
    Christensen KR; Beach TG; Serrano GE; Kanaan NM
    Acta Neuropathol Commun; 2019 Feb; 7(1):29. PubMed ID: 30819250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-synaptic spread of tau pathology in vivo.
    Liu L; Drouet V; Wu JW; Witter MP; Small SA; Clelland C; Duff K
    PLoS One; 2012; 7(2):e31302. PubMed ID: 22312444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.
    Lace G; Savva GM; Forster G; de Silva R; Brayne C; Matthews FE; Barclay JJ; Dakin L; Ince PG; Wharton SB;
    Brain; 2009 May; 132(Pt 5):1324-34. PubMed ID: 19321462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.
    Abey A; Davies D; Goldsbury C; Buckland M; Valenzuela M; Duncan T
    Brain Pathol; 2021 Jan; 31(1):144-162. PubMed ID: 32810333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy.
    Walker JM; Richardson TE; Farrell K; Iida MA; Foong C; Shang P; Attems J; Ayalon G; Beach TG; Bigio EH; Budson A; Cairns NJ; Corrada M; Cortes E; Dickson DW; Fischer P; Flanagan ME; Franklin E; Gearing M; Glass J; Hansen LA; Haroutunian V; Hof PR; Honig L; Kawas C; Keene CD; Kofler J; Kovacs GG; Lee EB; Lutz MI; Mao Q; Masliah E; McKee AC; McMillan CT; Mesulam MM; Murray M; Nelson PT; Perrin R; Pham T; Poon W; Purohit DP; Rissman RA; Sakai K; Sano M; Schneider JA; Stein TD; Teich AF; Trojanowski JQ; Troncoso JC; Vonsattel JP; Weintraub S; Wolk DA; Woltjer RL; Yamada M; Yu L; White CL; Crary JF
    J Neuropathol Exp Neurol; 2021 Jan; 80(2):102-111. PubMed ID: 33367843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic ablation of tau in postnatal neurons rescues decreased adult hippocampal neurogenesis in a tauopathy model.
    Houben S; Leroy K; Ando K; Yilmaz Z; Widomski C; Buée L; Brion JP
    Neurobiol Dis; 2019 Jul; 127():131-141. PubMed ID: 30818066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 and tau concurrence in the entorhinal subfields in primary age-related tauopathy and preclinical Alzheimer's disease.
    Llamas-Rodríguez J; Oltmer J; Marshall M; Champion S; Frosch MP; Augustinack JC
    Brain Pathol; 2023 Jul; 33(4):e13159. PubMed ID: 37037195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PART is part of Alzheimer disease.
    Duyckaerts C; Braak H; Brion JP; Buée L; Del Tredici K; Goedert M; Halliday G; Neumann M; Spillantini MG; Tolnay M; Uchihara T
    Acta Neuropathol; 2015 May; 129(5):749-56. PubMed ID: 25628035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophy associated with tau pathology precedes overt cell death in a mouse model of progressive tauopathy.
    Fung CW; Guo J; Fu H; Figueroa HY; Konofagou EE; Duff KE
    Sci Adv; 2020 Oct; 6(42):. PubMed ID: 33067235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal subfield pathologic burden in Lewy body diseases vs. Alzheimer's disease.
    Coughlin DG; Ittyerah R; Peterson C; Phillips JS; Miller S; Rascovsky K; Weintraub D; Siderowf AD; Duda JE; Hurtig HI; Wolk DA; McMillan CT; Yushkevich PA; Grossman M; Lee EB; Trojanowski JQ; Irwin DJ
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):707-721. PubMed ID: 32892355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.
    Crescenzi R; DeBrosse C; Nanga RP; Byrne MD; Krishnamoorthy G; D'Aquilla K; Nath H; Morales KH; Iba M; Hariharan H; Lee VM; Detre JA; Reddy R
    Hippocampus; 2017 Mar; 27(3):285-302. PubMed ID: 27997993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.